Smarter, safer

medical imaging

– powered by

nanotechnology.

We engineer novel contrast agents that equip physicians with the tools to make more accurate disease diagnoses and provide patients with more personalized, more effective treatments.

Adaptable

Our platform technology is designed to meet the variability of disease states and the healthcare needs of tomorrow.

Lucid

Nanoxort contrast agents produce brighter images for more accurate readings that allow for more reliable detection and monitoring to determine the best course of action.

Empathic

Through the precise control of nanoscale properties, our diagnostic solutions prioritize patient safety, comfort, and compliance.

The diversity in our opinions leads us to be more creative in our problem-solving. For Nanoxort, innovation means our solutions at the nanoscale become solutions for the people who seek and provide healthcare.

Dr. Allan David

Co-founder

Dr. Tareq Anani

Co-founder

Dr. Barry Yeh

Co-founder / General Manager

Dr. Abhinav Sannidhi

R&D Manager / Principal Investigator

Our partners help us create opportunities for scientists who strive to innovate in nanotechnology, advance the MRI contrast market, and leave a positive impact on people's lives and the communities around them.

* Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation